Mesoblast (ASX:MSB) - Key People
ASX:MSB · Directors, executives and key personnel · 12 month lookback
Mentioned in
Healthcare Wrap - Week 34 (17 Aug -> 21 Aug) 2026
22 Aug 2026
Mesoblast Completes Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain
17 Aug 2026
Healthcare Wrap - Week 31 (27 July -> 31 July) 2026
1 Aug 2026
Mesoblast Posts US$115M Ryoncil Revenue as Adult Trials and CAR Tech Advance
30 July 2026
Also Mentioned
People named in Mesoblast (ASX:MSB) articles over the last 12 months, by frequency.
Paul Hughes
· 34 articles
Steve Dabkowski
· 34 articles
Caroline Nelson
· 25 articles
Emma Neal
· 9 articles
Gregory George
· 5 articles
Philip J. Facchina - Chair of the Board
· 3 articles
Silviu Itescu - Chief Executive Officer and Managing Director
· 3 articles
Eric Rose - Chief Medical Officer
· 3 articles
James O'Brien - Chief Financial Officer
· 3 articles
Teresa Montagut - Clinical Development and Medical Affairs Head
· 3 articles
Lyn Cobley - Audit and Risk Committee Chair
· 3 articles
Gregory George - Non-Executive Director and credit facility provider
· 3 articles
Philip Krause - Non-Executive Director
· 3 articles
Aravindhan Veerapandiyan
· 2 articles
Philip Facchina
· 2 articles
Eric Rose
· 2 articles
James M. O’Brien
· 2 articles
Willi M Burns
· 2 articles
Lyn Cobley
· 2 articles
Jane Bell
· 2 articles